Objective To examine the relationship between the severity of depressive symptoms and the burden through diabetes care, or diagnosed diabetes in patients with type 2 diabetes, irrespective of the diabetic complications and glycemic control. Patients and Methods Subjects were 126 outpatients with type 2 diabetes who completed the Beck Depression Inventory-II (BDI-II), Problem Areas in Diabetes (PAID) scale, and Short Form-36 (SF-36).
Introduction
The prevalence of depression among patients with diabetes is 1.5 to 3 times higher than in the general population (1, 2) . In patients with diabetes, depression has been related to an increased risk of diabetic vascular complications (3), poor glycemic control (4) , and non-adherence to treatment and self-management behaviors (5) (6) (7) . To date, even the direction of the cause-effect relationship between depression and diabetes is a controversial issue (10) (11) (12) (13) (14) (15) (16) . At least, it is considered that the presence of physical diabetic complications such as blindness and end-stage renal disease may be a strong risk factor for depression. Among individuals with diabetes not having such severe complications, however, the emotional burden due to being treated as a diabetic patient may be responsible for the severity of depressive symptoms independent of physical complications. Therefore, the current study examine if there is a relationship between emotional distress due to diabetes and the severity of depressive symptoms among individuals after controlling for the effect of physical complications.
One of the most valuable goals for treating diabetes is to maintain a high quality of life as well as to prevent the diabetic complications. Preceding studies had suggested that QOL of the patients with diabetes is negatively affected by depression (8, 9) . We also evaluate the degrees to which the severity of depressive symptoms is related to quality of life not only from the mental aspect but also the physical aspect, independent of the severity of the diabetic complications, glycemic control, and other demographic characteristics, such as age and sex.
Materials and Methods

Study population
We surveyed outpatients with diagnosed type 2 diabetes who were followed in the Division of Diabetes, Metabolism, and Endocrinology of the Department of Internal Medicine at the Jikei University Hospital, in Tokyo, Japan. Potentially eligible patients were identified through an outpatient registry from September 2004 through March 2007. The diagnosis of type 2 diabetes was confirmed by review of the medical records. We excluded the patients with a history of diagnosis or treatment of depressive symptoms or other psychiatric disorders. We also excluded the patients with severe visual disturbance or cognitive disorder, those who had difficulty in providing informed consent, or participating in the study. Each subject was selected using a table of random numbers, from potentially eligible patients in an outpatient repository. Study subjects gave informed consent for completing survey instruments and participating in interviews. We included 126 patients with type 2 diabetes. This study was approved by the ethical committees of the Jikei University Hospital.
Demographic and clinical covariates
Data on demographic and clinical characteristics (duration of diabetes, complications and treatments, past history, and other diseases) were surveyed through interviews and manual review of the medical records. Laboratory data were retrieved from the hospital's central repository. Microvascular complications were defined as a diagnosis of one or more of these complications in the patient's medical records or history of an abnormal lab value from the hospital's central repository, i.e., nephropathy, microalbuminuria, renal failure, nephrotic syndrome, dialysis, retinopathy, photocoagulation, abnormality of Achilles tendon reflex, and paresthesia or sensory disturbance of the lower extremities. Macrovascular complications, i.e., ischemic heart disease, cerebrovascular disease, and arteriosclerosis obliterans (ASO), were defined as a history of or receiving care for these diseases.
Survey instruments
Severity of depressive symptoms
The widely used Beck Depression Inventory-II (BDI-II) reliably informs clinicians of the presence and severity of depressive symptoms. BDI-II screens for disease severity/depressive symptoms based on the Diagnostic and Statistical Manual, 4th edition (DSM-IV, 1994) criteria (17) . It includes 21 items rated on a 4-point scale (0 to 3). It enables evaluation of the severity of depressive symptoms during the previous two weeks. The assessment has a minimum score of 0 and a maximum score of 63. Disease severity is divided into four grades: 0-13 is "none or slightly depressed," 14-19 is "mildly depressed," 20-28 is "moderately depressed," and 29 and above is "severely depressed." As for the Japanese edition, equivalence with the first edition of a question item is evaluated (17) .
Comprehensive health-related QOL
The Short Form-36 (SF-36) ver. 2, Japanese edition, was used to measure comprehensive health-related quality of life (HRQOL). This measure provides scores related to both the physical and mental dimensions of HRQOL (18) . This scale consists of 36 items, which constitute eight subscales: physical function (PF), role physical (RP), bodily pain (BP), general health perceptions (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH). These eight subscales can be reduced to two summary scores related to the overall physical component summary (PCS) and mental component summary (MCS) that quantify health-related quality of life in the physical and psychological domains. The PCS is calculated from PF, RP, BP, GH, and VT. The MCS is calculated from GH, VT, SF, RE, and MH. PCS and MCS ranged from 0 to 100, with high scores indicating a good quality of life in those dimensions. PCS and MCS of 50 represented the norm for the general Japanese population in the Japanese edition.
Diabetes-related emotional distress (disease-specific QOL)
The Japanese edition of the Problem Areas in Diabetes (PAID) questionnaire was used to assess the disease-specific QOL. PAID is a 20-item self-report measure of diabetesrelated emotional distress with high internal reliability, sensitivity to change, and clinical utility (19, 21) . It includes 20 questions that assess diabetes-related stressors. The questions are framed as, "From your own perspective, to what degree are the following diabetes-related issues currently a problem for you?" with a 5-point scale to rate each item (ranging from 1= not a problem to 5= serious problem). The score is rescaled from 0 to 100, with a high score indicating lower disease-specific QOL or greater emotional distress from diabetes.
Statistical analysis
We used Spearman's correlations to assess associations between BDI-II scores and PCS, MCS, PAID score, and clinical/demographic covariates expressed by continuous variables. We used analysis of variance (ANOVA) and Wilcoxon rank-sum test to assess the differences in BDI-II Mental component summary (MCS) (SD) 52. 8 (8.8) score among the clinical/demographic covariates expressed by discrete variables. To adjust for the effect of confounding variables such as demographic and clinical characteristics, multiple regression models were employed. The level of significance was set at p<0.05. All statistical analyses were carried out using the STATA ver. 8.2 computer package.
Results
The characteristics of the 126 patients with type 2 diabetes are shown in Table 1 . Of the 126 patients, 27 (21.4%) were female, and the mean (SD) age was 63.2 (11.2) years. The mean (SD) known duration of diabetes was 14.6 (9.3) years. Sixty-seven (53.2%) patients were treated with oral hypoglycemic agents (OHA) and 65 (51.6%) with insulin. Among the patients who used insulin, 39 were on intensive therapy. The mean (SD) HbA1c of the participants recruited was 7.4 (1.2) %.
Diabetic proliferative retinopathy was reported in the medical records of 21 (16.7%) patients and nephropathy in 62 (49.2%) patients. Among the patients with nephropathy, chronic renal failure was reported in 12 patients. Neuropathy, defined as an abnormality of deep tendon reflexes or decreased sensation in the lower extremities, was detected in 52 (41.3%) patients. Ischemic heart disease was reported in 11 (8.7%) patients and cerebrovascular disease in 13 (10.3%). Arteriosclerosis obliterans (ASO) was reported in 8 (6.3%) patients.
The mean scores for BDI-II, SF-36 summary scores, and PAID assessments are shown in Table 1 . Patients who scored 14 or more on the BDI-II were defined as having a positive screen for depression. There were 14 out of 126 patients (11.1%) who fulfilled this criterion.
Associations between BDI-II and PAID, and SF-36
Univariate correlations between scores on the BDI-II and PAID, SF-36, age, duration of diabetes, and HbA1c are shown in Table 2 . Elevated BDI-II scores were associated with an increased PAID score and decreased PCS and MCS. This indicates that increased severity of depressive symptoms was related to increased diabetes-related emotional distress and poorer physical and psychological functions. Age, duration of diabetes, and HbA1c were not significantly related to the BDI-II score.
BDI-II and diabetic complications
The mean scores of BDI-II with and without diabetic complications are shown in Table 2 . The BDI-II score tended to be higher in the subjects with retinopathy (worse than proliferative retinopathy), nephropathy (worse than chronic renal failure), and clinical neuropathy (abnormality of Achilles tendon reflex and paresthesia or sensory disturbance of the lower extremities), than in the subjects without these complications. However, these relationships were not statistically significant. Conversely, the BDI-II score tended to be lower in the presence of cerebrovascular disease, ischemic heart disease, and ASO, but these relationships were also not statistically significant.
BDI-II and medications and their adverse effects
The mean scores of the BDI-II did not differ according to whether subjects were treated with OHAs or insulin, or according to the presence or absence of adverse effects of treatment, such as hypoglycemia (Table 2) .
Multiple regression analyses: relationship between the severity of depressive symptoms and diabetesrelated emotional distress (disease-specific QOL)
We identified factors making independent contributions to BDI-II scores using multiple regression analysis. The likelihood ratio test was used to examine whether the PAID score improves the regression model. Dummy variables were created for the number of microangiopathies and macroan- giopathies to reduce the number of independent variables. Two regression models were made; model 1 and model 2. In model 1, the BDI-II score was dependent variable, and sex, age, known duration of diabetes, HbA1c, the number of microangiopathies/macroangiopathies, use of OHA/insulin, and the occurrence of frequent hypoglycemic attacks (more than once a week) were independent variables as potential confounding factors. In model 2, the PAID score was also included as the independent variable. We used the likelihood ratio test of model 1 vs. model 2.
In model 1, there were no factors making independent contributions to the BDI-II score (adjusted R 2 = -0.0065). The associations of these independent variables and the BDI-II score are shown in Table 3 .
In model 2, the factor making an independent contribution to the BDI-II score was the PAID score (standardized coefficient, 0.17; p<0.001, adjusted R 2 =0.29). The likelihood ratio test of model 1 vs. model 2 indicated that the additional independent variable PAID score improved the model significantly (p<0.001). Model 2 also showed that the PAID score made a significant contribution to the BDI-II score independent after controlling for the contributions of demographic and clinical factors.
Multiple regression analyses: relationship between the severity of depressive symptoms and comprehensive QOL
We determined, using regression models, whether the severity of depressive symptoms had an adverse contribution to the comprehensive QOL, independent of clinical illnesses, and demographic variables; such as age and sex, where the PCS and MCS were dependent variables, and BDI-II score, demographic characteristics, and clinical illnesses were independent variables. Table 4 shows the factors that are associated with the comprehensive QOL of patients with type 2 diabetes. The factors that significantly lowered PCS were BDI-II score (standardized coefficient = -0.95, p<0.001), age (-0.43, p<0.001), number of macroangiopathies (-8.90, p< 0.001), and occurrence of frequent hypoglycemic attacks (-12.05, p = 0.02). The factor that significantly reduced MCS was the BDI-II score (-0.90, p<0.001). Age increased MCS significantly (0.13, p<0.05). These findings show that severity of depressive symptoms in patients with type 2 diabetes affect to the lower comprehensive QOL (especially the physical component), independent of diabetic complications, therapeutic regimens, adverse effect of diabetic care, and glycemic control. 
Discussion
The objective of the present study was to examine the relationship between the severity of depressive symptoms and diabetes-related emotional distress in patients with type 2 diabetes and to identify whether the relationship is independent of demographic and clinical characteristics, such as sex, age, duration of diabetes, glycemic control, and diabetic complications. Several preceding studies have indicated that there is a significant relationship between diabetes and the prevalence of depressive symptoms (1, 2, 20) ; however, the causal mechanisms and direction of the relationship are unclear. Some recent prospective studies have suggested that diabetes is related to the prevalence and incidence of depression or depressive symptoms (13, 14) , and others have suggested that the association is in the other direction (15, 16) . Therefore, it is possible there is a bidirectional association between depression and diabetes. However, these studies have not shown the causal mechanisms of the relationship or the factors that are intermediate between diabetes and depression. If there is a bidirectional association between depression and diabetes, and diabetes is a risk factor for the development of depression or the deterioration of depressive symptoms, we suggest that diabetes-related emotional distress is one of the causal mechanisms of the relationship. However, our cross-sectional study design was not able to verify the causal mechanisms. Even though we have conducted this study under this limitation, it is meaningful to indicate that the relationship is independent of demographic and clinical characteristics. We conducted multivariate analysis by the regression model, to examine this statistical independency.
The present findings indicated that diabetes-related emotional distress (PAID) was significantly related to the severity of depressive symptoms. On multivariate analysis, we found that this relation was statistically independent of the demographic and clinical characteristics, and therapeutic regimens. Preceding studies have pointed out the possibility that the effects of depression may result in poor glycemic control, poor prognosis of diabetic complications, and other clinical covariates (5, 6) . Additionally, a prospective study that referred to the possibility of an increased risk of depression among patients with diabetes indicated that the increased risk was mainly observed in patients with poor glycemic control (13) . However, we suggest that it is insufficient only to consider the glycemic control, state of complications, and other clinical covariates, when we estimate the possibility of the presence or severity of depressive symptoms in patients with diabetes, despite the fact that the causal relationship between depression and diabetes is unclear.
An earlier study has indicated that the impact of treatments, complications, and comorbidities has an adverse effect on HRQOL in individuals with diabetes (22) . We have also determined the association between comprehensive QOL and the severity of depressive symptoms in patients with type 2 diabetes, and whether the association is significant after adjusting for confounding factors (age, sex, severity of diabetic complications, and glycemic control, regimens of treatments, and adverse effects of treatments). On multivariate analysis, age, the number of macroangiopathies, the occurrence of frequent hypoglycemic attacks, and the BDI-II score significantly adversely affected the physical component of QOL. This finding supports the possibility that physical as well as mental QOL would be worsened by the severity of depressive symptoms in patients with diabetes, independent of the effect of age, sex, severity of diabetic complications, glycemic control, and regimens of treatments. There are several limitations to this study. First, we may not have a sufficiently large sample size to detect significant correlations among complicated microangiopathies, macroangiopathies, and the severity of depressive symptoms. The prevalence of microangiopathies was 9 to 17% and macroangiopathies 6 to 10%. The BDI-II scores of the participants with proliferative retinopathy and clinical neuropathy tended to be higher than the scores of the participants without these complications. However, these relationships were not statistically significant.
The second limitation is that the patients who were suspected of having depression according to the BDI-II score did not receive confirmation of the diagnosis by a psychiatrist. There was only one patient who was diagnosed with depression. However, seven patients refused to be examined by a psychiatrist. Therefore, we could not determine a multivariate regression model that includes the clinical diagnosis of depression as a dependent variable.
As mentioned above, the third limitation is a methodological problem of the cross-sectional study design. Our cross-sectional study design was not able to verify the causal relationship between the severity of depressive symptoms and diabetes-related emotional distress or diseasespecific/comprehensive QOL.
Depression is a risk factor for mortality in coronary heart disease (CHD) in the general population (23) . The most common cause of death in patients with adult-onset diabetes is CHD (24) , and depression or depressive symptoms elevate the mortality risk among the patients with diabetes (25, 26) . It is unclear whether the higher mortality risk due to depression among patients with diabetes is related to the poor prognosis of diabetic complications or other factors, such as the higher risk of suicide. Depression or depressive symptoms should be considered as major factors that affect various clinical states and physical domains of QOL in patients with diabetes. Our findings suggest that we should consider the possibility of depression or depressive symptoms in any individual with diabetes-related emotional distress. Additionally, some prospective studies need to be carried out to investigate the hypothesis that diabetes-related emotional distress is one of the major causes of the development of depressive symptoms among patients with diabetes.
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